TCL Archive Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery. February 13, 2004
TCL Archive Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer February 29, 2008
TCL Archive In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.” July 29, 2005